Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours.

British journal of cancer - 2 Nov 2001

Jefferies S, Edwards S M, Hamoudi R A, A'Hern R, Foulkes W, Goldgar D, Eeles R

Abstract excerpt

There is increasing evidence that predisposition to some cancers has a genetic component. There is a high incidence of loss of heterozygosity on chromosome 9, in the region of tumour suppressor gene, CDKN2A (also known as p16), in sporadic squamous cell cancer of the head and neck (SCCHN). To investigate the possibility that CDKN2A may be involved in the inherited susceptibility to SCCHN, the 3 coding exons of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Chromosomes, Human, Pair 9

Share to Cyclin-Dependent Kinase Inhibitor p16

Share to Germ-Line Mutation

Share to Head and Neck Neoplasms

Share to Loss of Heterozygosity

Share to Neoplasms, Second Primary

Source

Open in PubMed Open full text

Identifiers

PMID: 11720478
DOI: 10.1054/bjoc.2001.2068
PMCID: PMC2375247

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours.PMID 11720478Read ↗

Hereditary oral squamous cell carcinoma associated with CDKN2A germline mutation: a case report.Semantic proximity Read ↗

Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancersSemantic proximity Read ↗

Mutational analysis of CDKN2A genes in patients with squamous cell carcinoma of the skin.Semantic proximity Read ↗

Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck.Semantic proximity Read ↗

No CDKN2 mutations in neuroblastomas.Semantic proximity Read ↗

Infrequent p16/CDKN2 alterations in squamous cell carcinoma of the oesophagus.Semantic proximity Read ↗

High prevalence of p16 genetic alterations in head and neck tumours.Semantic proximity Read ↗

High frequency of loss of heterozygosity on chromosome region 9p21-p22 but lack of p16INK4a/p19ARF mutations in greek patients with basal cell carcinoma of the skin.Semantic proximity Read ↗

Mutation screening analysis of the retinoblastoma related gene RB2/p130 in sporadic ovarian cancer and head and neck squamous cell cancer.Semantic proximity Read ↗

p16INK4a inactivation is not frequent in uncultured sporadic primary cutaneous melanoma.Semantic proximity Read ↗

Mutation rate of the CDKN2 gene in malignant gliomas.Semantic proximity Read ↗

Absence of p16 gene (CDKN2) deletions in microdissected primary breast carcinoma specimens.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.